Something that@Boffin99, posted in the other forum, I found quite interesting.
"Synergistic inhibition of melanoma xenografts by Brequinar sodium and Doxorubicin
"-
90% Tumor Regression, That is huge.
Not sure, if RAC is doing Zantrene +Doxo on Melanoma, but would be good to find out.
Considering, Zantrene is much more potent than Brequinar and also has heart protection benefits, Melanoma patients would benefit immensely from this trial. IMHO.
General Comments / Chat, page-5248
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
0.095(7.22%) |
Mkt cap ! $234.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.41 | $1.32 | $249.8K | 182.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2826 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 40000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.37 |
Change
0.095 ( 6.64 %) |
||||
| Open | High | Low | Volume | ||
| $1.34 | $1.41 | $1.32 | 16145 | ||
| Last updated 15.53pm 10/05/2024 ? | |||||
| RAC (ASX) Chart |